Article info
PDFStudent essay
High court should not restrict access to puberty blockers for minors
- Correspondence to Cameron Beattie, Medical Sciences Division, University of Oxford, Oxford OX3 9DU, UK; cameron.beattie{at}stcatz.ox.ac.uk
Citation
High court should not restrict access to puberty blockers for minors
Publication history
- Received November 4, 2020
- Revised January 9, 2021
- Accepted January 15, 2021
- First published February 16, 2021.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Two dilemmas for medical ethics in the treatment of gender dysphoria in youth
- Gender dysphoria in adolescents: can adolescents or parents give valid consent to puberty blockers
- Assessment and support of children and adolescents with gender dysphoria
- Child abuse and its legislation: the global picture
- Lives in a chiaroscuro. Should we suspend the puberty of children with gender identity disorder
- The limits of parental responsibility regarding medical treatment decisions
- Longitudinal Outcomes of Gender Identity in Children (LOGIC): protocol for a prospective longitudinal cohort study of children referred to the UK gender identity development service
- Adolescent autonomy revisited: clinicians need clearer guidance
- Doctors can decide if children are able to consent to puberty blockers, say judges
- Hormone supplementation for pubertal induction in girls